Engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF . as of 3 days the ascending volatile is going thoroughly. and even were facing the pandemic, the company still on going for the products what we need and helps it a lot. hope for the better of the company it go up to 44 and so on. Anyone feel like it will run more?